Chugai Pharmaceutical
(OTC) CHGCF
Chugai Pharmaceutical Financials at a Glance
Market Cap
$90.34B
Revenue (TTM)
$1.30T
Net Income (TTM)
$454.62B
EPS (TTM)
$1.82
P/E Ratio
30.16
Dividend
$0.81
Beta (Volatility)
0.13 (Low)
Dividend
$0.81
Beta (Volatility)
0.13 (Low)
Price
$52.64
Volume
1,657
Open
$52.90
Price
$52.64
Volume
1,657
Open
$52.90
Previous Close
$52.64
Daily Range
$52.64 - $52.93
52-Week Range
$38.68 - $68.08
Dividend
$0.81
Beta (Volatility)
0.13 (Low)
Price
$52.64
Volume
1,657
Open
$52.90
Previous Close
$52.64
Daily Range
$52.64 - $52.93
52-Week Range
$38.68 - $68.08
CHGCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Chugai Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
7,872
CEO
Osamu Okuda
Website
www.chugai-pharm.co.jpHeadquarters
Chuo, 103-8324, JP
CHGCF Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
48%
Net Income Margin
35%
Return on Equity
24%
Return on Capital
32%
Return on Assets
20%
Earnings Yield
3.32%
Dividend Yield
1.46%
Payout Ratio
99.07%
Stock Overview
Market Cap
$90.34B
Shares Outstanding
1.65B
Volume
1.66K
Avg. Volume
6.66K
Financials (TTM)
Gross Profit
$895.03B
Operating Income
$590.71B
EBITDA
$631.92B
Operating Cash Flow
$389.79B
Capital Expenditure
$76.34B
Free Cash Flow
$313.45B
Cash & ST Invst.
$980.55B
Total Debt
$25.73B
Chugai Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$323.77B
+12.2%
Gross Profit
$230.40B
+14.8%
Gross Margin
71.16%
N/A
Market Cap
$90.34B
N/A
Market Cap/Employee
$17.98M
N/A
Employees
5,026
N/A
Net Income
$116.14B
+19.4%
EBITDA
$172.55B
+25.9%
Quarterly Fundamentals
Net Cash
$837.83B
-11.3%
Accounts Receivable
$355.16B
+20.5%
Inventory
$290.10B
+24.5%
Long Term Debt
$17.62B
N/A
Short Term Debt
$0.00
N/A
Return on Assets
19.96%
N/A
Return on Invested Capital
31.69%
N/A
Free Cash Flow
$111.40B
+149.9%
Operating Cash Flow
$124.18B
+86.2%